Nutrition Research
Volume 29, Issue 2 , Pages 89-93 , February 2009

A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma

  • Shigeyuki Takeshita

      Affiliations

    • The First Department of Internal Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 95 819 7260; fax: +81 95 849 7270.
    • ,
  • Tatsuki Ichikawa

      Affiliations

    • The First Department of Internal Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan
    • ,
  • Kazuhiko Nakao

      Affiliations

    • The First Department of Internal Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan
    • ,
  • Hisamitsu Miyaaki

      Affiliations

    • The First Department of Internal Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan
    • ,
  • Hidetaka Shibata

      Affiliations

    • The First Department of Internal Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan
    • ,
  • Toshihisa Matsuzaki

      Affiliations

    • The First Department of Internal Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan
    • ,
  • Toru Muraoka

      Affiliations

    • The First Department of Internal Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan
    • ,
  • Takuya Honda

      Affiliations

    • The First Department of Internal Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan
    • Department of Internal Medicine, Japanese Red Cross Nagasaki Atomic Bomb Hospital, Nagasaki, Japan
    • ,
  • Masashi Otani

      Affiliations

    • The First Department of Internal Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan
    • ,
  • Motohisa Akiyama

      Affiliations

    • The First Department of Internal Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan
    • ,
  • Satoshi Miuma

      Affiliations

    • The First Department of Internal Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan
    • ,
  • Esuke Ozawa

      Affiliations

    • The First Department of Internal Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan
    • ,
  • Masumi Fujimito

      Affiliations

    • The First Department of Internal Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan
    • ,
  • Katsumi Eguchi

      Affiliations

    • The First Department of Internal Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan

Received 16 November 2008 ,Revised 16 December 2008 ,Accepted 30 December 2008.

References 

  1. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis. 1999;19:271–285
  2. Llovet JM. Update treatment approach to hepatocellular carcinoma. J Gastroenterol. 2005;40:225–235
  3. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35:1164–1171
  4. Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, et al. Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet. 2002;359:1734–1739
  5. London WT. Primary hepatocellular carcinoma—etiology, pathogenesis, and prevention. Hum Pathol. 1981;12:1085–1097
  6. Lautz HU, Selverg O, Körber J, Bürger M, Müller MJ. Protein-calorie malnutrition in liver cirrhosis. Clin Investig. 1992;70:478–486
  7. Müller MJ, Lauts HU, Plogmann B, Bürger M, Körber J, Schmidt FW. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology. 1992;15:782–794
  8. Crawford DH, Shepherd RW, Halliday JW, Cooksley GW, Golding SD, Cheng WS, et al. Body composition in nonalcoholic cirrhosis: the effect of disease etiology and severity on nutritional compartments. Gastroenterology. 1994;106:1611–1617
  9. Italian Multicentre Cooperative Project on Nutrition in Liver Cirrhosis . Nutritional status in cirrhosis. J Hepatol. 1994;21:317–335
  10. Nielsen K, Kondrup J, Martinsen L, Døssing H, Larsson B, Stilling B, et al. Nutritional assessment and adequacy of dietary intake in hospitalized patients with alcoholic cirrhosis. Br J Nutr. 1993;69:665–679
  11. Bismuth H, Morino M, Sherlock D, Castaing D, Miglietta C, Cauquil P, et al. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg. 1992;163:387–394
  12. Yamada R, Kishi K, Sonomura T, Tsuda M, Nomura S, Satoh M. Transcatheter arterial embolization in unresectable hepatocellular carcinoma. Cardiovasc Intervent Radiol. 1990;13:135–139
  13. Stuart K, Stokes K, Jenkins R, Trey C, Clouse M. Treatment of hepatocellular carcinoma using doxorubicin/ethiodized oil/gelatin powder chemoembolization. Cancer. 1993;72:3202–3209
  14. Kajiwara K, Okuno M, Kobayashi T, Honma N, Maki T, Kato M, et al. Oral supplementation with branched chain amino acids improves survival rate of rats with carbon tetrachloride-induced liver cirrhosis. Dig Dis Sci. 1998;43:1572–1579
  15. Yoshida T, Muto Y, Moriwaki H, Yamato M. Effect of long-term oral supplementation with branched chain amino acid granules on the prognosis of liver cirrhosis. J Gastroenterol. 1989;24:692–698
  16. Marchesini G, Dioguardi FS, Bianchi GP, Zoli M, Bellati G, Roffi L, et al. Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy: a randomized double blind casein-controlled trial. J Hepatol. 1990;11:92–101
  17. Marchesine G, Bianchi G, Merli M, Amodio P, Panella C, Loguercio C, et al. Nutritional supplementation with branched chain amino acids in advanced cirrhosis: a doubled-blind, randomized trial. Gastroenterology. 2003;124:1792–1801
  18. Nakaya Y, Okita K, Suzuki K, Moriwaki H, Kato A, Miwa Y, et al. BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition. 2007;23:113–120
  19. Hisataka M, Yoshiyuki M, Masahiro T, Masahiko K, Hideki F, Makoto S, et al. Branched-chain amino acids as a protein- and energy-source in liver cirrhosis. Biochem Biophys Res Commun. 2004;313:405–409
  20. Tomiya T, Omata M, Fujiwara K. Significance of branched chain amino acids as possible stimulators of hepatocyte growth factor. Biochem Biophys Res Commun. 2004;313:411–416
  21. Poon RT, Yu WC, Fan ST, Wong J. Long-term oral branched chain amino acids in patients undergoing chemoembolization for hepatocellular carcinoma: a randomized trial. Aliment Pharmacol Ther. 2004;19:779–788
  22. Kudo M, Okanoue T Japan Society of Hepatology. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Oncology. 2007;72(suppl 1):2–15
  23. Okamoto M, Sakaida I, Tsuchiya M, Suzuki C, Okita K. Effect of a late evening snack on the blood glucose level and energy metabolism in patients with liver cirrhosis. Hepatol Res. 2003;27:45–50
  24. Tsuchiya M, Sakaida I, Okamoto M, Okita K. The effect of late evening snack in patients with liver cirrhosis. Hepatol Res. 2005;31:95–103
  25. Merli M, Riggio O, Dally L. Does malnutrition affect survival in cirrhosis?. Hepatology. 1996;23:1041–1046
  26. Andersen H, Borre M, Jakobsen J, Andersen PH, Vilstrup H. Decreased muscle strength in patients with alcoholic liver cirrhosis in relation to malnutritional status, alcohol abstinence, liver function, and neuropathy. Hepatology. 1998;27:1200–1206
  27. Yoshida T, Muto Y, Moriwaki H, Yamato M. Effect of long-term oral supplementation with branched-chain amino acid granules on the prognosis of liver cirrhosis. J Gastroenterol. 1989;24:692–698
  28. Ijichi C, Matsumura T, Tsuji T, Eto Y. Branched-chain amino acids promote albumin synthesis in rat primary hepatocytes through the mTOR signal transduction system. Biochem Biophys Res Commun. 2003;303:59–64
  29. Okuno M, Moriwaki M, Kato M, Muto S, Kojima S. Changes in the ratio of branched-chain to aromatic amino acids affect the secretion of albumin in cultured rat hepatocytes. Biochem Biophys Res Commun. 1995;214:1045–1050
  30. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–483
  31. Meng WC, Leung KL, Ho RL, Leung TW, Lau WY. Prospective randomized control study on the effect of branched-chain amino acids in patients with liver resection for hepatocellular carcinoma. Aust N Z J Surg. 1999;69:811–815
  32. Long-term oral administration of branched chain amino acids after curative resection of hepatocellular carcinoma: a prospective randomized trial. The San-in Group of Liver Surgery. Br J Surg. 1997;84:1525–1531
  33. Yamamoto M, Iwasa M, Matsumura K, Nakagawa Y, Fujita N, Kobayashi Y, et al. Improvement of regional cerebral blood flow after oral intake of branched-chain amino acids in patients with cirrhosis. World J Gastroenterol. 2005;11:6792–6799
  34. Nakamura I, Ochiai K, Imai Y, Moriyasu F, Imawari M. Restoration of innate host defense responses by oral supplementation of branched-chain amino acids in decompensated cirrhotic patients. Hepatol Res. 2007;37:1062–1067

PII: S0271-5317(09)00002-5

doi: 10.1016/j.nutres.2008.12.005

Nutrition Research
Volume 29, Issue 2 , Pages 89-93 , February 2009

Article Tools